Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
34019 | 117 | 44.2 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
518 | 3 | ANGIOGENESIS//RETINOPATHY OF PREMATURITY//ENDOSTATIN | 20826 |
361 | 2 | ANGIOGENESIS//ENDOSTATIN//VEGF | 17372 |
34019 | 1 | ANGINEX//ENDOTOXIN NEUTRALIZING//TUMOR ANGIOGENESIS | 117 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANGINEX | authKW | 2557674 | 12% | 70% | 14 |
2 | ENDOTOXIN NEUTRALIZING | authKW | 782964 | 3% | 100% | 3 |
3 | TUMOR ANGIOGENESIS | address | 710459 | 6% | 39% | 7 |
4 | ANGIOGENESIS | address | 346164 | 24% | 5% | 28 |
5 | ANGIOGENEISIS | address | 260988 | 1% | 100% | 1 |
6 | ANGIOGENESIA | address | 260988 | 1% | 100% | 1 |
7 | ANGIOGENET | address | 260988 | 1% | 100% | 1 |
8 | AV3B INTEGRIN | authKW | 260988 | 1% | 100% | 1 |
9 | BETA PEP 25 | authKW | 260988 | 1% | 100% | 1 |
10 | CLIN CHEM MED BLI | address | 260988 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 571 | 37% | 0% | 43 |
2 | Pathology | 93 | 9% | 0% | 10 |
3 | Biochemistry & Molecular Biology | 59 | 22% | 0% | 26 |
4 | Cell Biology | 55 | 13% | 0% | 15 |
5 | Biophysics | 40 | 8% | 0% | 9 |
6 | Gastroenterology & Hepatology | 35 | 6% | 0% | 7 |
7 | Medicine, Research & Experimental | 20 | 6% | 0% | 7 |
8 | Immunology | 18 | 8% | 0% | 9 |
9 | Hematology | 15 | 4% | 0% | 5 |
10 | Biology | 11 | 3% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMOR ANGIOGENESIS | 710459 | 6% | 39% | 7 |
2 | ANGIOGENESIS | 346164 | 24% | 5% | 28 |
3 | ANGIOGENEISIS | 260988 | 1% | 100% | 1 |
4 | ANGIOGENESIA | 260988 | 1% | 100% | 1 |
5 | ANGIOGENET | 260988 | 1% | 100% | 1 |
6 | CLIN CHEM MED BLI | 260988 | 1% | 100% | 1 |
7 | CNRS ECOLE SUPER BIOTECHNOL STRASBOURG | 260988 | 1% | 100% | 1 |
8 | CURSO POS PATOL CIENCIAS CLIN | 260988 | 1% | 100% | 1 |
9 | EUGENE BRAUNWALD BRIGHAM WOMENS HOSP | 260988 | 1% | 100% | 1 |
10 | INT GROWTH DEV | 260988 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 3138 | 3% | 0% | 3 |
2 | REVISTA BRASILEIRA DE MEDICINA VETERINARIA | 1212 | 1% | 0% | 1 |
3 | CANCER JOURNAL - FRANCE | 1072 | 1% | 0% | 1 |
4 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 725 | 1% | 0% | 1 |
5 | PHARMACOLOGICAL REVIEWS | 371 | 1% | 0% | 1 |
6 | CANCER LETTERS | 340 | 3% | 0% | 4 |
7 | AMERICAN JOURNAL OF PATHOLOGY | 325 | 3% | 0% | 4 |
8 | INTERNATIONAL JOURNAL OF CANCER | 317 | 4% | 0% | 5 |
9 | INTERNATIONAL JOURNAL OF PANCREATOLOGY | 281 | 1% | 0% | 1 |
10 | CLINICAL CANCER RESEARCH | 276 | 3% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANGINEX | 2557674 | 12% | 70% | 14 | Search ANGINEX | Search ANGINEX |
2 | ENDOTOXIN NEUTRALIZING | 782964 | 3% | 100% | 3 | Search ENDOTOXIN+NEUTRALIZING | Search ENDOTOXIN+NEUTRALIZING |
3 | AV3B INTEGRIN | 260988 | 1% | 100% | 1 | Search AV3B+INTEGRIN | Search AV3B+INTEGRIN |
4 | BETA PEP 25 | 260988 | 1% | 100% | 1 | Search BETA+PEP+25 | Search BETA+PEP+25 |
5 | COMPOUND 0118 | 260988 | 1% | 100% | 1 | Search COMPOUND+0118 | Search COMPOUND+0118 |
6 | EC HETEROGENEITY | 260988 | 1% | 100% | 1 | Search EC+HETEROGENEITY | Search EC+HETEROGENEITY |
7 | ECTOPIC LYMPH NODES | 260988 | 1% | 100% | 1 | Search ECTOPIC+LYMPH+NODES | Search ECTOPIC+LYMPH+NODES |
8 | ENDOTHELIAL RECEPTOR EXPRESSION | 260988 | 1% | 100% | 1 | Search ENDOTHELIAL+RECEPTOR+EXPRESSION | Search ENDOTHELIAL+RECEPTOR+EXPRESSION |
9 | EVLC2 | 260988 | 1% | 100% | 1 | Search EVLC2 | Search EVLC2 |
10 | ICA M 1 | 260988 | 1% | 100% | 1 | Search ICA+M+1 | Search ICA+M+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DINGS, RPM , VANG, KB , CASTERMANS, K , POPESCU, F , ZHANG, Y , EGBRINK, MGAO , MESCHER, MF , FARRAR, MA , GRIFFIOEN, AW , MAYO, KH , (2011) ENHANCEMENT OF T-CELL-MEDIATED ANTITUMOR RESPONSE: ANGIOSTATIC ADJUVANT TO IMMUNOTHERAPY AGAINST CANCER.CLINICAL CANCER RESEARCH. VOL. 17. ISSUE 10. P. 3134-3145 | 19 | 48% | 12 |
2 | GRIFFIOEN, AW , (2008) ANTI-ANGIOGENESIS: MAKING THE TUMOR VULNERABLE TO THE IMMUNE SYSTEM.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 57. ISSUE 10. P. 1553 -1558 | 16 | 50% | 39 |
3 | DIRKX, AEM , EGBRINK, MGAO , KUIJPERS, MJE , VAN DER NIET, ST , HEIJNEN, VVT , BOUMA-TER STEEGE, JCA , WAGSTAFF, J , GRIFFIOEN, AW , (2003) TUMOR ANGIOGENESIS MODULATES LEUKOCYTE-VESSEL WALL INTERACTIONS IN VIVO BY REDUCING ENDOTHELIAL ADHESION MOLECULE EXPRESSION.CANCER RESEARCH. VOL. 63. ISSUE 9. P. 2322-2329 | 16 | 47% | 98 |
4 | BO, WJ , DE, WM , XIAO, LE , FENG, DD , (2012) ADVANCES AND PROSPECTS OF ANGINEX AS A PROMISING ANTI-ANGIOGENESIS AND ANTI-TUMOR AGENT.PEPTIDES. VOL. 38. ISSUE 2. P. 457 -462 | 18 | 37% | 0 |
5 | DINGS, RPM , LEVINE, JI , BROWN, SG , ASTORGUES-XERRI, L , MACDONALD, JR , HOYE, TR , RAYMOND, E , MAYO, KH , (2013) POLYCATIONIC CALIXARENE PTX013, A POTENT CYTOTOXIC AGENT AGAINST TUMORS AND DRUG RESISTANT CANCER.INVESTIGATIONAL NEW DRUGS. VOL. 31. ISSUE 5. P. 1142-1150 | 11 | 52% | 9 |
6 | DIRKX, AEM , EGBRINK, MGAO , CASTERMANS, K , VAN DER SCHAFT, DWJ , THIJSSEN, VLJL , DINGS, RPM , KWEE, L , MAYO, KH , WAGSTAFF, J , STEEGE, JCABT , ET AL (2006) ANTI-ANGIOGENESIS THERAPY CAN OVERCOME ENDOTHELIAL CELL ANERGY AND PROMOTE LEUKOCYTE-ENDOTHELIUM INTERACTIONS AND INFILTRATION IN TUMORS.FASEB JOURNAL. VOL. 20. ISSUE 6. P. 621-630 | 15 | 39% | 72 |
7 | DINGS, RPM , VAN LAAR, ES , LOREN, M , WEBBER, J , ZHANG, Y , WATERS, SJ , MACDONALD, JR , MAYO, KH , (2010) INHIBITING TUMOR GROWTH BY TARGETING TUMOR VASCULATURE WITH GALECTIN-1 ANTAGONIST ANGINEX CONJUGATED TO THE CYTOTOXIC ACYLFULVENE, 6-HYDROXYLPROPYLACYLFULVENE.BIOCONJUGATE CHEMISTRY. VOL. 21. ISSUE 1. P. 20 -27 | 11 | 44% | 23 |
8 | VAN MOURIK, TR , LAPPCHEN, T , ROSSIN, R , VAN BEIJNUM, JR , MACDONALD, JR , MAYO, KH , GRIFFIOEN, AW , NICOLAY, K , GRULL, H , (2015) EVALUATION OF IN-111-LABELED ANGINEX AS POTENTIAL SPECT TRACER FOR IMAGING OF TUMOR ANGIOGENESIS.ANTICANCER RESEARCH. VOL. 35. ISSUE 11. P. 5945 -5954 | 13 | 35% | 0 |
9 | DINGS, RPM , VAN LAAR, ES , WEBBER, J , ZHANG, Y , GRIFFIN, RJ , WATERS, SJ , MACDONALD, JR , MAYO, KH , (2008) OVARIAN TUMOR GROWTH REGRESSION USING A COMBINATION OF VASCULAR TARGETING AGENTS ANGINEX OR TOPOMIMETIC 0118 AND THE CHEMOTHERAPEUTIC IROFULVEN.CANCER LETTERS. VOL. 265. ISSUE 2. P. 270-280 | 13 | 36% | 14 |
10 | DINGS, RPM , HASEMAN, JR , MAYO, KH , (2008) PROBING STRUCTURE-ACTIVITY RELATIONSHIPS IN BACTERICIDAL PEPTIDE BETA PEP-25.BIOCHEMICAL JOURNAL. VOL. 414. ISSUE . P. 143-150 | 13 | 36% | 5 |
Classes with closest relation at Level 1 |